Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Dementia test results are designed to measure cognitive function and detect possible memory problems, but the scores themselves don’t automatically mean someone has dementia. These screening tests—like the MMSE (Mini-Mental State Examination) or MoCA (Montreal Cognitive Assessment)—are starting points that flag whether a person’s thinking and memory skills may be below what’s expected for their age and education level. If you or a loved one just received results saying “mild cognitive impairment” or a specific score, that’s the beginning of a diagnostic conversation with a doctor, not a confirmed diagnosis.
The actual diagnosis of dementia requires additional testing including blood work, brain imaging, and a comprehensive medical evaluation. Think of dementia screening tests like a blood pressure check at a routine doctor’s visit—an important initial measurement that might tell you something needs further investigation, but not the full story on its own. A single screening score can’t account for all the factors that affect how someone performs on a cognitive test, including education level, language barriers, anxiety during testing, or underlying treatable conditions like vitamin deficiencies or urinary tract infections. Understanding what your test results actually mean involves knowing which test was used, what the score means within normal ranges, and what steps come next.
Table of Contents
- What Do Dementia Screening Tests Actually Measure?
- Understanding MMSE and MoCA Scores
- The Critical Impact of Education and Demographics
- What a Normal Result Actually Means (and Doesn’t)
- When Results Don’t Match What You Observe at Home
- Emerging Blood Tests and Earlier Detection
- What Happens After Screening Results
- Conclusion
What Do Dementia Screening Tests Actually Measure?
Cognitive screening tests are designed to assess memory, attention, language, and problem-solving abilities in 10 to 30 minutes. They’re not deep neuropsychological evaluations—those are longer, more detailed tests done by specialists. A screening test gives doctors a quick picture of whether someone appears to have cognitive changes worth investigating further. The tests ask questions like “What year is it?” “Can you name three objects I show you?” “Can you do this simple math?” and “Can you copy this drawing?” The answers and abilities demonstrated get scored against normal ranges.
The key limitation here is that screening tests only detect cognitive impairment; they can’t determine the underlying cause. That’s why a person with a below-normal screening score might actually have depression, sleep apnea, a vitamin B12 deficiency, or a urinary tract infection—all of which can impair thinking and memory but are treatable. One real-world example is an older adult who scores poorly on a cognitive screening, receives follow-up blood work that shows severe vitamin B12 deficiency, receives treatment, and then scores normally on retesting weeks later. This happens more often than many people realize.
Understanding MMSE and MoCA Scores
The MMSE (Mini-Mental State Examination) is one of the oldest and most widely used screening tools, developed in 1975 and still common in primary care offices and hospitals. Scores range from 0 to 30. A score of 27–30 is normal—what you’d expect for someone without cognitive impairment. A score of 21–26 suggests mild cognitive impairment that warrants monitoring and possibly more detailed testing. Scores between 11–20 point to moderate impairment, and below 10 suggests severe impairment.
The important caveat: the MMSE misses mild cognitive impairment about 75% to 82% of the time, meaning many people with early thinking problems pass this test. The MoCA (Montreal Cognitive Assessment) is more sensitive, catching mild cognitive impairment 90–100% of the time compared to the MMSE. A MoCA score of 26 or higher is normal, 18–25 indicates mild cognitive impairment, and 10–17 suggests moderate impairment. Because the MoCA is more thorough and catches earlier changes, it’s become increasingly popular in neurology and memory clinics, though it takes a bit longer to administer. Here’s a practical difference: an 68-year-old might score 24 on an MMSE (which would be considered normal or very mild) but score 19 on a MoCA (which would flag mild cognitive impairment). The MoCA’s sensitivity means it’s more likely to identify people who actually need follow-up care.
The Critical Impact of Education and Demographics
One major factor that affects test results is education level, and it’s something many people don’t realize can skew the results. The MoCA specifically recommends adding one point to the score if someone has fewer than 12 years of formal education, because education level significantly influences how someone performs on verbal and problem-solving questions. This is a documented limitation: someone with a high school education or less might score lower on a cognitive test even though their actual cognitive function is normal. Similarly, language barriers, cultural differences, and anxiety during the test can all affect performance.
This is why no single test result should be taken in isolation. A 75-year-old who left school at age 14 to work on a farm, speaks English as a second language, and feels nervous in a doctor’s office might score lower on screening tests than her actual cognitive abilities warrant. A comprehensive cognitive evaluation includes accounting for these factors. The SAGE test, a 12-question self-administered screening that covers memory, problem-solving, and language, offers an alternative option that some find less intimidating, though it still carries the same limitations.
What a Normal Result Actually Means (and Doesn’t)
If someone receives a normal screening test result, that’s reassuring news—their thinking, memory, and problem-solving appear to be functioning as expected for their age and education level. But here’s an important limitation to understand: a normal screening test result doesn’t completely rule out dementia. Early-stage dementia might not show up on a brief screening test. Some cognitive changes are subtle and only become apparent in longer, more detailed testing.
Additionally, some types of dementia affect different brain areas—for instance, a person with frontotemporal dementia might fail tests of personality and impulse control but do fine on a standard memory test initially. The practical takeaway: if someone has normal screening results but still has cognitive complaints, or if family members have noticed changes in thinking or behavior, the doctor should continue evaluating rather than dismissing concerns. On the flip side, if screening results are abnormal, that opens the door to the proper diagnostic pathway, which is actually helpful because some causes are reversible. This is why getting results explained clearly matters—understanding what a score means guides the next appropriate step.
When Results Don’t Match What You Observe at Home
One of the most frustrating situations families encounter is when a loved one scores surprisingly well on a screening test but family members have clearly noticed memory problems or behavioral changes. This happens for a few reasons. First, some people perform better in a structured, quiet doctor’s office than they do in everyday life. Second, screening tests assess specific cognitive domains and might miss the types of changes that are most noticeable at home—like difficulty managing finances, poor judgment, or getting lost in familiar places.
Third, some people have developed coping strategies that help them get through a test but don’t reflect their actual cognitive struggles. Another scenario is the opposite: someone scores lower on screening and gets referred for further testing, only to have more detailed neuropsychological evaluation show that they don’t meet criteria for dementia. Anxiety, depression, sleep deprivation, or even distraction during testing can lower scores. This is why doctors don’t make a diagnosis based on one screening test alone. The full diagnostic pathway includes a detailed history from the patient and family, physical and neurological examination, blood tests to rule out treatable conditions, and often brain imaging like an MRI or PET scan.
Emerging Blood Tests and Earlier Detection
One of the most significant developments in dementia diagnosis is the emergence of blood tests that can detect biomarkers of Alzheimer’s disease years before symptoms or cognitive changes appear on screening tests. These tests measure substances like phosphorylated tau and amyloid-beta, which accumulate in the brain in Alzheimer’s disease. A simple blood test could potentially identify people at risk decades before they notice memory problems, opening possibilities for earlier intervention.
As of 2025 and 2026, these tests are transitioning from research tools to clinical availability, though they’re not yet standard in all clinics. The promise of blood biomarkers is particularly significant because it could shift the diagnostic paradigm from waiting for symptoms to detecting disease processes early. However, it also raises new questions and decisions for people to consider—should someone be screened for dementia risk even if they feel fine? If a blood test shows amyloid accumulation, what does that mean for their future? For now, these tests are most useful in research settings and specialized clinics, but they represent a major shift in how dementia might be identified in the future.
What Happens After Screening Results
If screening test results suggest possible cognitive impairment, the next steps follow a clear diagnostic pathway. Your primary care doctor will typically order a full blood panel to check for treatable causes like vitamin B12 deficiency, thyroid problems, or other metabolic issues. They’ll review medications, since some medications can affect cognition. They’ll ask detailed questions about when changes began, whether there’s a family history of dementia, and how cognitive problems affect daily life. Depending on these findings, they may refer you to a neurologist or neuropsychologist for more detailed testing.
Many people also receive brain imaging—either an MRI or sometimes a PET scan—to look at brain structure and rule out other causes like stroke or brain tumors. This comprehensive approach might feel extensive, but it’s the right way to determine what’s actually going on. Sometimes it leads to a dementia diagnosis and discussion of treatment and planning. Sometimes it identifies a treatable condition, and the person improves significantly. Sometimes it shows normal aging changes and reassures the person and family. Whatever the outcome, you’ll have answers based on more than a screening test score, and that clarity helps guide the next decisions about care and planning.
Conclusion
Dementia screening test results tell you whether someone’s cognitive function falls within normal ranges or suggests impairment that needs investigation—but they don’t tell the complete story. The MMSE, MoCA, SAGE, and other screening tools are valuable starting points that help doctors identify who needs further evaluation. Scores must be interpreted in context: considering someone’s education level, language, and how they perform in everyday life. A score alone can’t diagnose dementia, rule out dementia, or explain what’s causing any cognitive changes.
If you’ve received screening test results that concern you, the next step is working with your doctor to understand what the score means for your particular situation and moving forward with appropriate follow-up testing. Some results lead to a dementia diagnosis and a clear care plan. Others identify treatable conditions or confirm that cognitive function is normal for your age. Whatever the outcome, a complete diagnostic evaluation gives you and your family answers, time to plan if needed, and potentially access to treatments or interventions that can help.
